Recent content from Burl Gilyard
Minnesota parents still struggling to find infant formula amid shortages
Abbott's Similac recall complicated an already tight supply of the crucial infant nutrition.
Another problem appears for Medtronic's HeartWare device
The company and government examined three instances when HeartWare users experienced pump thrombosis, a severe malfunction.
Boston Scientific raises full-year outlook as medical procedures regain momentum
Company posted first-quarter profit of $97 million.
Abbott Labs' profits jump on high winter demand for at-home COVID-19 tests
The medtech and diagnostics company with a sizable Minnesota presence saw profits rise 36.5%, but a Similac infant formula recall dampened its outlook.
Medtech makers say law change on R&D expenses hurts patients, innovation
Medtronic, Medical Alley and others in innovation-driven industries object to a tax law they say hinders life-changing developments.
Why are there so many Australian med-tech companies in Minnesota?
The med-tech connection between Minnesota and Australia keeps expanding, building on a history of shared specialties.
Rochester investment fund focuses on medtech, life sciences startups in region
Most of Minnesota's investment funds are headquartered in the Twin Cities, but Rochester group seeds companies largely in the southeast corner of the state.
Congressional subcommittee examines FDA handling of troubled Medtronic device
HeartWare was pulled from the market last year as growing clinical research suggested higher rate of stroke and death among patients with device.
Egg Medical hatches technology to shield health care workers from radiation
The Arden Hills company has landed $13 million in financing.
Minnesota's Cardiovascular Systems looks to add new products, broaden its business
The New Brighton medical technology firm, reliant chiefly on a single product over the last three decades, plans eight new ones in coming years.
Medtronic taps new leader for troubled diabetes division
Que Dallara joins the company from Honeywell. The med-tech giant also appoints two new unit presidents.
Minnesota pharmaceutical firm launches new drug — and with it, a rare disease unit
ANI Pharmaceuticals, a publicly traded company in Baudette, reported lackluster earnings Tuesday, but hopes new anti-inflammation medication will boost growth.
Minnetronix partners with Wisconsin company to launch concussion diagnostic device
EyeBox secured its latest FDA clearance in January for the small machine that tracks eye movement to detect a possible brain injury.
Sleep Number makes partnership to study any links between sleep patterns, cancer
Minneapolis-based company has partnered with American Cancer Society for six-year research project.
Today's inflation jolt hides the long-term strain of costs of services on Minnesotans' wallets
Big increases on meat and gas feel bad now, but hikes in costs of services have been far greater over time.
Arden Hills' Intricon selling for $241 million to private-equity group
Buyer Altaris Capital Partners is majority owner of Minnetronix Medical.
Medtronic donates new product to cancer screening in underserved areas
An outreach program to detect colorectal cancer, which affects Black people disproportionately, came as Medtronic disclosed mixed financial results.
St. Jude founder and Minnesota med-tech trailblazer is driven by heart
By every measure, Manny Villafana has had a successful career, but the serial entrepreneur is not done yet.
Boston Scientific's manufacturing expansion underway in Maple Grove
The company announced fourth-quarter results and outlined expansion details for its manufacturing facility in the Twin Cities suburb.
Abbott Laboratories, maker of at-home COVID tests, reports strong growth
Sales of pandemic-related products accounted for 20% of its fourth-quarter revenue.
FDA: Medtronic slow to update, recall defective insulin pumps for diabetes patients
The medical device company, with its operational headquarters in Fridley, said it is working to comply with the FDA findings.
Despite delays, Medtronic remains bullish on its robot system, Hugo
Manufacturing and supply chain constraints delayed shipments to new European customers, but the company says demand remains high.
Medtronic to acquire Affera, a cardiac arrhythmia technology firm, for $925 million
Affera makes cardiac mapping and navigation systems and catheter-based cardiac ablation technologies.
Greater MSP competing to land $100 million for biotech business cluster
The development organization named a finalist in federal competition.
With no competition, Minnesota maker of sleep apnea device doubled sales last year
Golden Valley-based Inspire Medical Systems saw demand soar for its implantable treatment in 2021.
National cannabis retailer Green Thumb buys Minnesota's LeafLine
New owner looks to grow state's small number of medical cannabis patients
Brooklyn Park picks up two more medtech firms: Switchback Medical and Cretex
The northern suburb is becoming home to more of the region's medical manufacturers.
Two Discovery Square to open for next wave of biotech collaboration with Mayo Clinic
Adjacent One Discovery Square is completely full
In busiest year for IPOs in decades, Minnesota firms deliver mixed returns for investors
Many companies stumbled after going public, floundering under investor scrutiny.
FDA issues warning to Medtronic's diabetes business
Federal regulators raised concerns over how the business division handled complaints, assessed product risks and dealt with recalls.
Fresh Vine, a wine maker with a Minnesota address, has a rough debut on Wall Street
The value of Fresh Vine Wine, the eighth Minnesota company with an IPO this year, dropped 30% in its first day of trading.
Vadnais Heights medtech firm adds German operation with latest acquisition
Lemon Medical in Hammelburg, Germany, is the third acquisition in three years for MGC Diagnostics.
Medtronic lowers sales outlook for the year amid pandemic's persisting impact
Profits topped expectations and emerging markets saw solid growth despite COVID-19 continuing to quell U.S. growth.
Northern Minnesota's ANI Pharmaceuticals closes on largest-ever acquisition
Generic drugmaker paying $197 million for New Jersey-based Novitium Pharma, the largest-ever deal in the publicly traded company's history
Medtronic partners with Amazon to bring the PillCam to your door
Remote endoscopy technology signals a new frontier for Minnesota medtech giant
Green Bay Packers kick off 'stock' sale
The Green Bay Packers kicked off a common "stock" sale on Tuesday. But the team, selling 300,000 shares at $300 per share, is quick to note: It's not really stock.
New Brighton-based Cardiovascular Systems hampered by COVID-19's grip on hospitals
The prolonged pandemic continues to overburden medical facilities, limiting growth for the medical device company.
Canadian Pacific outlines closure plans for U.S. HQ in Minneapolis after merger
Many of its downtown Minneapolis workers will be offered a chance to move to the combined company's new headquarters in Kansas City.
